Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
– Andy Williams, Co-Founder and CEO, to be a guest speaker on panel discussing Colorado cannabis market DENVER, Oct. 17, 2019 — Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or the “Company”) announced today that […]
Upon closing of pending acquisitions, the Company will operate a total of 14 dispensaries within Colorado- The acquisitions are part of MMT’s strategy aimed at creating an integrated operation, to include proven and profitable cultivation, […]
Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
